How can pharma make the most of digital technologies?

GSK forms strategic partnership with Alector to produce monoclonal antibodies for neurodegenerative diseases.

Find out how a random act of kindness set Antoinette Gawin on the path to becoming a VP in her twenties.

Can a new malaria vaccine hold the key to reliable, durable protection?

Edd Stone of TTP explains how the industry is overcoming the manufacturing challenges associated with cell therapies.

GlaxoSmithKline’s Senior Vice President of US Oncology speaks about the pandemic and its impact on patients.

What role can regulators play in overcoming the barriers to the adoption of continuous manufacturing processes?

Creating a patient-centric ecosystem in India.

How pharma can support patients with initial onboarding and ongoing adherence to therapeutic treatments.

Why is there a need for innovation in cell line development technology?